|
CETN3 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.115800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.718200E-01 |
| Normal-vs-Stage2 |
7.698600E-01 |
| Normal-vs-Stage3 |
4.021000E-01 |
| Normal-vs-Stage4 |
6.782200E-01 |
| Stage1-vs-Stage2 |
6.585400E-01 |
| Stage1-vs-Stage3 |
8.846200E-01 |
| Stage1-vs-Stage4 |
3.127600E-01 |
| Stage2-vs-Stage3 |
6.078200E-01 |
| Stage2-vs-Stage4 |
5.054000E-01 |
| Stage3-vs-Stage4 |
3.009600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.072400E-01 |
| Normal-vs-AfricanAmerican |
3.328800E-01 |
| Normal-vs-Asian |
2.801600E-01 |
| Caucasian-vs-AfricanAmerican |
4.580800E-01 |
| Caucasian-vs-Asian |
1.469960E-01 |
| AfricanAmerican-vs-Asian |
8.982000E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.148200E-01 |
| Normal-vs-Female |
8.678400E-01 |
| Male-vs-Female |
1.343850E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.050400E-01 |
| Normal-vs-Extreme_Weight |
5.556200E-01 |
| Normal-vs-Obese |
3.822800E-01 |
| Normal-vs-Extreme_Obese |
4.646600E-01 |
| Normal_Weight-vs-Extreme_Weight |
9.993600E-01 |
| Normal_Weight-vs-Obese |
7.499200E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.983600E-01 |
| Extreme_Weight-vs-Obese |
7.061600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
6.727600E-01 |
| Obese-vs-Extreme_Obese |
8.102000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.744600E-01 |
| Normal-vs-Age(41-60Yrs) |
7.905600E-01 |
| Normal-vs-Age(61-80Yrs) |
2.857600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.951400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.724800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.495400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.091200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.212800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.367400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.965200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.428200E-01 |
| Normal-VS-Type2 PRCC |
2.189200E-01 |
| Normal-VS-KIRP CIMP |
6.397000E-01 |
| Normal-VS-Unclassified PRCC |
8.897000E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.661000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
8.499600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
6.812800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.774200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
2.991400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.407400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.677570E-01 |
| Normal-vs-N1 |
7.690200E-01 |
| Normal-vs-N2 |
4.735800E-01 |
| N0-vs-N1 |
3.320200E-01 |
| N0-vs-N2 |
8.603800E-01 |
| N1-vs-N2 |
5.422400E-01 |
|
|
